Phase 1/2 study of GBS-01 in patients with gemcitabine-refractory advanced pancreatic cancer.

Trial Profile

Phase 1/2 study of GBS-01 in patients with gemcitabine-refractory advanced pancreatic cancer.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 Dec 2016

At a glance

  • Drugs GBS 01 (Primary)
  • Indications Pancreatic cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Kracie Pharma
  • Most Recent Events

    • 17 Jan 2013 Status changed from suspended to completed as reported by University Hospital Medical Information Network - Japan.
    • 17 Jul 2012 Status changed from recruiting to suspended as reported by University Hospital Medical Information Network - Japan.
    • 18 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top